[1]王 猛,党星波,周永春,等.地舒单抗治疗老年性骨质疏松疗效及对患者骨密度、骨代谢的影响[J].陕西医学杂志,2023,52(10):1395-1398.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.025]
　WANG Meng,DANG Xingbo,ZHOU Yongchun,et al.Efficacy of denosumab in treatment of senile osteoporosis and its effect on bone mineral density and bone metabolism[J].,2023,52(10):1395-1398.[doi:DOI:10.3969/j.issn.1000-7377.2023.10.025]
点击复制

地舒单抗治疗老年性骨质疏松疗效及对患者骨密度、骨代谢的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
52
期数:
2023年10期
页码:
1395-1398
栏目:
药物与临床
出版日期:
2023-10-05

文章信息/Info

Title:
Efficacy of denosumab in treatment of senile osteoporosis and its effect on bone mineral density and bone metabolism
作者:
王 猛; 党星波; 周永春; 刘建敏
(陕西省人民医院急诊外科,陕西 西安 710068)
Author(s):
WANG Meng; DANG Xingbo; ZHOU Yongchun; LIU Jianmin
(Department of Emergency Surgery,Shaanxi Provincial People's Hospital,Xi'an 710068,China)
关键词:
骨质疏松;  地舒单抗;  对照研究;  骨密度;  老年人
Keywords:
Osteoporosis;  Denosumab;  Controlled study;  Bone mineral density;  Old people
分类号:
R 681
DOI:
DOI:10.3969/j.issn.1000-7377.2023.10.025
文献标志码:
A
摘要:
目的:探究地舒单抗治疗老年性骨质疏松疗效及对患者骨密度、骨代谢的影响。方法:选取120例老年性骨质疏松患者,采用半随机对照试验方法,分为对照组、治疗组各60例,对照组接受碳酸钙D3联合骨化三醇口服治疗,治疗组在碳酸钙D3联合骨化三醇的基础上,接受地舒单抗注射治疗。比较两组治疗前、随访3、6 个月时疼痛情况、骨密度(BMD)和生化指标变化及不良反应。结果:治疗组疼痛缓解较对照组明显,比较差异有统计学意义(P<0.05); 治疗组BMD较对照组明显升高(P<0.05); 治疗组钙磷水平较对照组低,两组患者碱性磷酸酶水平比较则无统计学差异(P>0.05)。结论:地舒单抗是治疗老年性骨质疏松的有效药物,在常规治疗基础上,地舒单抗可抑制骨吸收,提高 BMD,减轻患者的疼痛症状。
Abstract:
Objective:To observe the efficacy of denosumab in the treatment of senile osteoporosis and its effect on bone mineral density and bone metabolism.Methods:A total of 120 patients with senile osteoporosis were selected and divided into control group and treatment group by semi-randomized controlled trial method,with 60 cases in each group.The control group was treated with calcium carbonate D3 combined with calcitriol,and the treatment group was treated with denosumab injection on the basis of calcium carbonate D3 combined with calcitriol.The pain,bone mineral density(BMD),biochemical indexes and complications were compared between the two groups before treatment,3 months and 6 months after follow-up.Results:The pain relief in the treatment group was significantly better than that in the control group(P<0.05).BMD in the treatment group was significantly higher than that in the control group(P<0.05).Calcium and phosphorus levels were lower in the treatment group than in the control group,while alkaline phosphatase levels were not significantly different between the two groups(P>0.05).Conclusion:Denosumab is an effective drug for the treatment of senile osteoporosis.Combined with conventional treatment,denosumab can inhibit bone resorption,improve BMD and relieve pain symptoms.

参考文献/References:

[1] 邹远妩,王建利,王 卓,等.血清骨钙素和骨密度检测在中老年健康体检中的应用价值[J].陕西医学杂志,2018,47(5):662-664,677.
[2] Arceo-Mendoza RM,Camacho PM.Postmenopausal osteoporosis:Latest guidelines[J].Endocrinology and Metabolism Clinics of North America,2021(2):50.
[3] 中华医学会骨质疏松和骨矿盐疾病分会.中国骨质疏松症流行病学调查及“健康骨骼”专项行动结果发布[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(4):317-318.
[4] 夏维波.地舒单抗在骨质疏松症临床合理用药的中国专家建议[J].中华骨质疏松和骨矿盐疾病杂志,2020,13(6):499-508.
[5] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J].中国实用内科杂志,2018,38(2):127-150.
[6] Cummings SR,San MJ,Mcclung MR.Denosumab for prevention of fractures in postmenopausal women with osteoporosis[J].The New EnglandJournal of Medicine,2009,8:361.
[7] 彭 净,姜开杰,任晓蕾,等.基于美国FDA不良事件报告系统数据库的地舒单抗风险信号挖掘[J].药物不良反应杂志,2022,24(2):7.
[8] 余晓波.骨质疏松症的临床研究进展[J].中国医学创新,2022,19(21):4.
[9] Raisz LG.Pathogenesis of osteoporosis:Concepts,conflicts,and prospects[J].Journal of Clinical Investigation,2005,115(12):3318.
[10] 丁 超,孙 强.老年性骨质疏松症相关问题研究进展[J].中国骨质疏松杂志,2016,21(3):372-375.
[11] 管晶晶,陈 宇,汤华冬,等.骨质疏松的健康管理发展现状及挑战[J].中华全科医学,2021,19(10):1729-1732.
[12] 邹 军,章 岚,任 弘,等.运动防治骨质疏松专家共识[J].中国骨质疏松杂志,2015,20(11):1291-1302,1306.
[13] 马远征,王以朋,刘 强,等.中国老年骨质疏松诊疗指南(2018)[J].中国老年学杂志,2019,39(11):2557-2575.
[14] 葛继荣,王和鸣,郑洪新,等.中医药防治原发性骨质疏松症专家共识(2020)[J].中国骨质疏松杂志,2020,25(12):1717-1725.
[15] 吴兴净,陶周善,龚延海,等.鲑鱼降钙素联合骨化三醇治疗老年椎体压缩性骨折伴慢性肾功能不全患者椎体成形术后骨质疏松疗效观察[J].陕西医学杂志,2022,51(9):1133-1136,1162.
[16] 周大标,吴冰心,阳 越,等.基于肝脾肾探讨绝经后骨质疏松症治疗机制[J].陕西中医,2022,51(6):752-754,766.
[17] 温明韬,梁学振,李嘉程,等.基于网络药理学与分子对接技术探讨六味地黄丸抗骨质疏松症的机制研究[J].中国骨质疏松杂志,2021,27(8):1129-1134,1153.
[18] 郭小兰,董 博,姚 洁.益气补肾法治疗原发性骨质疏松症疗效观察[J].陕西中医,2017,38(10):1434-1435.
[19] 范引科,李 雅,姜珊珊,等.补肾方防治原发性骨质疏松实验研究[J].陕西中医,2015,34(6):760-761.
[20] Lacey DL,Boyle J,Simonet WS,et al.Bench to bedside:Elucidation of the OPG-RANK-RANKL pathway and the development of denosumab[J].Nature Reviews Drug Discovery,2012,11(5):401-419.
[21] 郭 梁.成骨细胞,破骨细胞及OPG/RANKL/RANK轴与骨质疏松症[J].中医正骨,2010,22(7):41-44.
[22] 于佳丽,何 娜,邱婷婷,等.地舒单抗注射液治疗骨质疏松症的单中心回顾性分析[J].中国合理用药探索,2022,19(7):1-6.
[23] 傅淑平,蔡 宇,张荣华.成骨细胞在破骨细胞性骨吸收中的调节作用[J].陕西医学杂志,2004,33(11):1040-1041,1048.
[24] 史传道,段永峰,贾文鹏,等.抗疏健骨颗粒对去势骨质疏松大鼠骨碱性磷酸酶、尿羟脯氨酸的影响[J].陕西中医,2009,30(6):739-740.
[25] 夏 涛.甲状旁腺激素(1-34)联合鲑鱼降钙素对绝经后骨质疏松压缩性骨折患者骨密度、骨代谢的影响[J].陕西医学杂志,2018,47(11):1480-1482,1486.

相似文献/References:

[1]郭向东,马 波△.2型糖尿病患者血清胰岛素水平与骨代谢关联研究*[J].陕西医学杂志,2019,(1):77.
　GUO Xiangdong,MA Bo..Association between serum insulin level and bone metabolismin patients with type 2 diabetes mellitus[J].,2019,(10):77.
[2]郭晓昀 ,赵秋艳,刘 娟△ ,等.基于微信公众平台延续康复管理在椎体成形术后的效果观察*[J].陕西医学杂志,2019,(6):715.
[3]李 杰,邱裕生△.骨水泥灌注空心椎弓根螺钉内固定治疗不稳定性胸腰椎骨折合并骨质疏松临床疗效研究[J].陕西医学杂志,2019,(8):1021.
　LI Jie,QIU Yusheng..Polymethylmethacrylate augmented pedicle screw instrumentation fixation combined for osteoporotic thoracolumbar unstable fractures[J].,2019,(10):1021.
[4]王荣锋,郁 昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,(8):1032.
　WANG Rongfeng,YU Hao,JIANG Xinjian..The relationship between serum 25 hydroxy vitamin D and osteoporosis in elderly diabetic patients[J].,2019,(10):1032.
[5]王 荣,贾爱华,刘新艳 ,等.IGF1及其相关性因素对2型糖尿病并发骨质疏松的影响研究[J].陕西医学杂志,2019,(9):1163.
　WANG Rong,JIA Aihua,LIU Xinyan,et al.The effect of IGF1 and its related factors in type 2 diabetes complicated with osteoporosis[J].,2019,(10):1163.
[6]李 鹏,佘新安,赵东军,等.骨髓间充质干细胞对大鼠骨质疏松股骨干骨折早期愈合影响的实验研究[J].陕西医学杂志,2021,50(7):793.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.006]
　LI Peng,SHE Xin'an,ZHAO Dongjun,et al.Effect of bone marrow mesenchymal stem cells on early healing of femoral shaft fracture in osteoporotic rats[J].,2021,50(10):793.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.006]
[7]王建武,李晓妮,赵 强,等.调控miR-152对骨质疏松大鼠模型骨生物力学、骨重建平衡及骨组织Hedgehog信号通路的影响[J].陕西医学杂志,2022,51(8):944.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.009]
　WANG Jianwu,LI Xiaoni,ZHAO Qiang,et al.Effect of regulating miR-152 on bone biomechanics,bone remodeling balance and Hedgehog signal pathway in osteoporosis rat model[J].,2022,51(10):944.[doi:DOI:10.3969/j.issn.1000-7377.2022.08.009]
[8]方 宇,董重阳,高斌礼,等.微小RNA-214靶向调控PTEN对成骨细胞MC3T3-E1增殖、分化、矿化的影响及机制研究[J].陕西医学杂志,2023,52(12):1619.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.001]
　FANG Yu,DONG Chongyang,GAO Binli,et al.Effects of miR-214 on proliferation,differentiation and mineralization of osteoblast MC3T3-E1 by targeting PTEN and its mechanism[J].,2023,52(10):1619.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.001]
[9]李克鹏,孟令辰,谷同同,等.老年二次脆性骨折风险自评预测模型建立及临床应用价值[J].陕西医学杂志,2024,(2):226.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.017]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(82172418); 陕西省科技厅社会发展领域项目(2022SF-474); 陕西省人民医院科技拔尖计划科研项目(2021BJ-28)
更新日期/Last Update: 2023-10-07